Global Tuberculosis Vaccine Treatment Market Size, Share, Trends and Forecast 2022-2030

Description

Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.

Industry Insights

Due to the COVID-19 pandemic, the global Tuberculosis Vaccine Treatment market size is estimated to be worth US$ 74 million in 2021 and is forecast to a readjusted size of US$ 91 million by 2028 with a CAGR of 2.9% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tuberculosis Vaccine Treatment market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tuberculosis Vaccine Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.

The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.

Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.

Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.

Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.

This report focuses on Tuberculosis Vaccine Treatment volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tuberculosis Vaccine Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Tuberculosis Vaccine Treatment market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Immune Vaccine

Therapy Vaccine

Segment by Application

Self-Procurement

UNICEF

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck

Japan BCG Lab

Serum Institute of India

AJ Vaccines

BioFarma

GreenSignal Bio Pharma

China National Biotec

Biomed Lublin

Taj Pharmaceuticals

Ataulpho de Paiva

IVAC

Queen Saovabha Mem. Inst

Microgen

TABLE OF CONTENT

1 Tuberculosis Vaccine Treatment Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccine Treatment

1.2 Tuberculosis Vaccine Treatment Segment by Type

1.2.1 Global Tuberculosis Vaccine Treatment Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Immune Vaccine

1.2.3 Therapy Vaccine

1.3 Tuberculosis Vaccine Treatment Segment by Application

1.3.1 Global Tuberculosis Vaccine Treatment Sales Comparison by Application: (2022-2028)

1.3.2 Self-Procurement

1.3.3 UNICEF

1.3.4 Other

1.4 Global Tuberculosis Vaccine Treatment Market Size Estimates and Forecasts

1.4.1 Global Tuberculosis Vaccine Treatment Revenue 2017-2028

1.4.2 Global Tuberculosis Vaccine Treatment Sales 2017-2028

1.4.3 Tuberculosis Vaccine Treatment Market Size by Region: 2017 Versus 2021 Versus 2028

2 Tuberculosis Vaccine Treatment Market Competition by Manufacturers

2.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2017-2022)

2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Tuberculosis Vaccine Treatment Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Tuberculosis Vaccine Treatment Manufacturing Sites, Area Served, Product Type

2.5 Tuberculosis Vaccine Treatment Market Competitive Situation and Trends

2.5.1 Tuberculosis Vaccine Treatment Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccine Treatment Players Market Share by Revenue

2.5.3 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Tuberculosis Vaccine Treatment Retrospective Market Scenario by Region

3.1 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Tuberculosis Vaccine Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Tuberculosis Vaccine Treatment Market Facts & Figures by Country

3.3.1 North America Tuberculosis Vaccine Treatment Sales by Country

3.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Tuberculosis Vaccine Treatment Market Facts & Figures by Country

3.4.1 Europe Tuberculosis Vaccine Treatment Sales by Country

3.4.2 Europe Tuberculosis Vaccine Treatment Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Tuberculosis Vaccine Treatment Market Facts & Figures by Region

3.5.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region

3.5.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Tuberculosis Vaccine Treatment Market Facts & Figures by Country

3.6.1 Latin America Tuberculosis Vaccine Treatment Sales by Country

3.6.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Tuberculosis Vaccine Treatment Market Facts & Figures by Country

3.7.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country

3.7.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Tuberculosis Vaccine Treatment Historic Market Analysis by Type

4.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)

4.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2017-2022)

4.3 Global Tuberculosis Vaccine Treatment Price by Type (2017-2022)

5 Global Tuberculosis Vaccine Treatment Historic Market Analysis by Application

5.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)

5.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2017-2022)

5.3 Global Tuberculosis Vaccine Treatment Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Merck Tuberculosis Vaccine Treatment Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Japan BCG Lab

6.2.1 Japan BCG Lab Corporation Information

6.2.2 Japan BCG Lab Description and Business Overview

6.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio

6.2.5 Japan BCG Lab Recent Developments/Updates

6.3 Serum Institute of India

6.3.1 Serum Institute of India Corporation Information

6.3.2 Serum Institute of India Description and Business Overview

6.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio

6.3.5 Serum Institute of India Recent Developments/Updates

6.4 AJ Vaccines

6.4.1 AJ Vaccines Corporation Information

6.4.2 AJ Vaccines Description and Business Overview

6.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio

6.4.5 AJ Vaccines Recent Developments/Updates

6.5 BioFarma

6.5.1 BioFarma Corporation Information

6.5.2 BioFarma Description and Business Overview

6.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.5.4 BioFarma Tuberculosis Vaccine Treatment Product Portfolio

6.5.5 BioFarma Recent Developments/Updates

6.6 GreenSignal Bio Pharma

6.6.1 GreenSignal Bio Pharma Corporation Information

6.6.2 GreenSignal Bio Pharma Description and Business Overview

6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio

6.6.5 GreenSignal Bio Pharma Recent Developments/Updates

6.7 China National Biotec

6.6.1 China National Biotec Corporation Information

6.6.2 China National Biotec Description and Business Overview

6.6.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.4.4 China National Biotec Tuberculosis Vaccine Treatment Product Portfolio

6.7.5 China National Biotec Recent Developments/Updates

6.8 Biomed Lublin

6.8.1 Biomed Lublin Corporation Information

6.8.2 Biomed Lublin Description and Business Overview

6.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio

6.8.5 Biomed Lublin Recent Developments/Updates

6.9 Taj Pharmaceuticals

6.9.1 Taj Pharmaceuticals Corporation Information

6.9.2 Taj Pharmaceuticals Description and Business Overview

6.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio

6.9.5 Taj Pharmaceuticals Recent Developments/Updates

6.10 Ataulpho de Paiva

6.10.1 Ataulpho de Paiva Corporation Information

6.10.2 Ataulpho de Paiva Description and Business Overview

6.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio

6.10.5 Ataulpho de Paiva Recent Developments/Updates

6.11 IVAC

6.11.1 IVAC Corporation Information

6.11.2 IVAC Tuberculosis Vaccine Treatment Description and Business Overview

6.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.11.4 IVAC Tuberculosis Vaccine Treatment Product Portfolio

6.11.5 IVAC Recent Developments/Updates

6.12 Queen Saovabha Mem. Inst

6.12.1 Queen Saovabha Mem. Inst Corporation Information

6.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Description and Business Overview

6.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio

6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates

6.13 Microgen

6.13.1 Microgen Corporation Information

6.13.2 Microgen Tuberculosis Vaccine Treatment Description and Business Overview

6.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Microgen Tuberculosis Vaccine Treatment Product Portfolio

6.13.5 Microgen Recent Developments/Updates

7 Tuberculosis Vaccine Treatment Manufacturing Cost Analysis

7.1 Tuberculosis Vaccine Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment

7.4 Tuberculosis Vaccine Treatment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Tuberculosis Vaccine Treatment Distributors List

8.3 Tuberculosis Vaccine Treatment Customers

9 Tuberculosis Vaccine Treatment Market Dynamics

9.1 Tuberculosis Vaccine Treatment Industry Trends

9.2 Tuberculosis Vaccine Treatment Market Drivers

9.3 Tuberculosis Vaccine Treatment Market Challenges

9.4 Tuberculosis Vaccine Treatment Market Restraints

10 Global Market Forecast

10.1 Tuberculosis Vaccine Treatment Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Type (2023-2028)

10.2 Tuberculosis Vaccine Treatment Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Application (2023-2028)

10.3 Tuberculosis Vaccine Treatment Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Tuberculosis Vaccine Treatment by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Tuberculosis Vaccine Treatment by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample